Sex hormones influence survival of patients with metastatic urothelial carcinoma undergoing immune checkpoint therapy

INTRODUCTION: Clinical trials investigating efficacy of immune checkpoint inhibitors (ICI) revealed sex-specific divergent outcomes in urothelial cancer (UC), suggesting that sex hormones might play an important role in gender-specific dimorphisms of response upon ICI. However, further clinical inve...

Descripción completa

Detalles Bibliográficos
Autores principales: Lindner, Andrea Katharina, Lackner, Felizian, Tymoszuk, Piotr, Barth, Dominik Andreas, Seeber, Andreas, Kocher, Florian, Toth, Bettina, Hochleitner, Margarethe, Pichler, Martin, Pichler, Renate
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243034/
https://www.ncbi.nlm.nih.gov/pubmed/37277835
http://dx.doi.org/10.1186/s13293-023-00522-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243034/
https://www.ncbi.nlm.nih.gov/pubmed/37277835
http://dx.doi.org/10.1186/s13293-023-00522-x

Ejemplares similares